NCT02753933

Brief Summary

This study aims to evaluate whether direct access from General Practitioners (GPs) to Magnetic Resonance Imaging (MRI) for patients with chronic headache decreases overall NHS costs and increases patient satisfaction compared to clinical practice with referral to Neurology Services.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
296

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

April 25, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 28, 2016

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

August 8, 2017

Status Verified

August 1, 2017

Enrollment Period

2.2 years

First QC Date

April 25, 2016

Last Update Submit

August 7, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • 6-month cost analysis per patient referred to either MRI or Neurology (measured in £ per patient)

    The primary objective is to evaluate whether direct access from General Practitioners (GPs) to Magnetic Resonance Imaging (MRI) for patients with chronic headache is associated with cost-savings at 6 months after the initial episode at Secondary Care (either an MRI scan or a Neurology Outpatient appointment) compared to clinical practice with referral to the Neurology Department.

    6 months after the initial episode at Secondary Care (either an MRI scan or Neurology Outpatient appointment)

Secondary Outcomes (8)

  • 12-month cost analysis per patient referred to either MRI or Neurology (measured in £ per patient)

    12 months after the initial episode at Secondary Care (either an MRI scan or Neurology Outpatient appointment)

  • 6-month cost-effectiveness analysis per patient referred to either MRI or Neurology (measured in £ per QALY)

    6 months after the initial episode at Secondary Care (either an MRI scan or Neurology Outpatient appointment)

  • 12-month cost-effectiveness analysis per patient referred to either MRI or Neurology (measured in £ per QALY)

    12 months after the initial episode at Secondary Care (either an MRI scan or Neurology Outpatient appointment)

  • Patient satisfaction associated with both clinical pathways (direct referral to MRI or Neurology)

    6 months

  • Patient's self perceived quality of life - measured using EQ-5D-5L questionnaire

    6 months

  • +3 more secondary outcomes

Study Arms (2)

MRI scan

Direct referral from Primary Care (GPs) to an MRI scan as the initial Secondary Care point of contact.

Other: MRI scan

Neurology Appointment

Referral from Primary Care (GPs) to Neurology Services in Secondary Care as the initial Secondary Care point of contact.

Other: Neurology Appointment

Interventions

MRI head scan to be performed as the first Secondary Care contact.

MRI scan

Outpatient appointment with Neurologist as the first Secondary Care contact

Neurology Appointment

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with chronic headache referred from Primary Care to Secondary Care to either an MRI scan or a Neurology outpatient appointment.

You may qualify if:

  • Every patient aged 16 years or over with: i) chronic headache as a primary cause that has lasted ≥ 15 days per month for more than 3 months; and ii) referred from GP practices to GSTT, either directly referred to an MRI exam or a Neurology outpatient appointment.

You may not qualify if:

  • Children under the age of 16;
  • Patients with red flags as defined in NICE guideline CG150;
  • Patients without chronic primary headache, i.e. a headache that has not persisted for ≥ 15 days per month for more than 3 months
  • Patients with headache referred through the two week wait list;
  • Patients who lack capacity to give consent or participate in the study;
  • Patients not fluent in English;
  • Prisoners;
  • Patients that are already taking part in a clinical trial of an investigational medicinal products (CTIMPs).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guy's and St Thomas' NHS Foundation Trust

London, SE1 7EH, United Kingdom

RECRUITING

Related Publications (1)

  • Rua T, Mazumder A, Akande Y, Margariti C, Ochulor J, Turville J, Razavi R, Peacock JL, McCrone P, Goh V, Shearer J, Afridi S. Management of chronic headache with referral from primary care to direct access to MRI compared with Neurology services: an observational prospective study in London. BMJ Open. 2020 Oct 16;10(10):e036097. doi: 10.1136/bmjopen-2019-036097.

MeSH Terms

Conditions

Headache Disorders

Interventions

Magnetic Resonance Spectroscopy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Asif Mazumder, MD

    Guy's and St Thomas' NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yvonne Akande, Master

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2016

First Posted

April 28, 2016

Study Start

April 1, 2016

Primary Completion

June 1, 2018

Study Completion

December 1, 2018

Last Updated

August 8, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will not share

Locations